Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO10 Inhibitors

FBXO10 inhibitors belong to a class of chemical compounds designed to specifically target and inhibit the activity of the protein FBXO10. FBXO10 is a critical component of the ubiquitin-proteasome system, which plays a fundamental role in the regulation of protein degradation within cells. The ubiquitin-proteasome system is responsible for the selective degradation of proteins that have fulfilled their cellular functions, are damaged, or need to be tightly controlled in order to maintain cellular homeostasis. FBXO10, as an F-box protein, serves as a substrate receptor within the Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligase complex, facilitating the ubiquitination and subsequent proteasomal degradation of specific target proteins. In essence, FBXO10 inhibitors are designed to disrupt this crucial cellular pathway by interfering with the binding and recognition of FBXO10 for its target proteins, thereby preventing their ubiquitination and degradation. FBXO10 inhibitors have garnered significant interest in the field of molecular biology and cell biology research. These compounds are valuable tools for investigating the functions and regulatory roles of FBXO10 in various cellular processes, including cell cycle regulation, DNA repair, and protein quality control. By inhibiting FBXO10, researchers can gain insights into the specific substrates it targets, allowing for a better understanding of how this protein contributes to the maintenance of cellular homeostasis and the progression of various diseases.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib binds to the 26S proteasome with high affinity and specificity, inhibiting its activity, which can indirectly affect FBXO10's role in protein degradation.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib is an irreversible proteasome inhibitor that can alter protein turnover, potentially affecting the degradation process in which FBXO10 is involved.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a reversible proteasome inhibitor that can inhibit the degradation of ubiquitinated proteins, thus indirectly impacting the pathway of FBXO10.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Ixazomib selectively and reversibly inhibits the 20S proteasome, which could affect the protein degradation pathway involving FBXO10.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

Oprozomib, an oral proteasome inhibitor, can interfere with proteasomal degradation, which may affect FBXO10's activity indirectly.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin irreversibly binds to and inhibits the proteasome, which can disrupt the normal functioning of FBXO10 in protein degradation.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is a selective and irreversible proteasome inhibitor, which can impede the proteolytic pathway that includes FBXO10.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

Delanzomib is a proteasome inhibitor that can disrupt the degradation of proteins, thus potentially influencing the biological processes in which FBXO10 participates.